DK1173172T3 - Synergistiske virkninger af amlodipin og den hydroxylerede metabolit af atorvastatin - Google Patents

Synergistiske virkninger af amlodipin og den hydroxylerede metabolit af atorvastatin

Info

Publication number
DK1173172T3
DK1173172T3 DK00928200T DK00928200T DK1173172T3 DK 1173172 T3 DK1173172 T3 DK 1173172T3 DK 00928200 T DK00928200 T DK 00928200T DK 00928200 T DK00928200 T DK 00928200T DK 1173172 T3 DK1173172 T3 DK 1173172T3
Authority
DK
Denmark
Prior art keywords
amlodipine
atorvastatin
synergistic effects
hydroxylated metabolite
hydroxylated
Prior art date
Application number
DK00928200T
Other languages
English (en)
Inventor
R Preston Mason
Original Assignee
R Preston Mason
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27494873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1173172(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Preston Mason filed Critical R Preston Mason
Application granted granted Critical
Publication of DK1173172T3 publication Critical patent/DK1173172T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK00928200T 1999-04-23 2000-04-18 Synergistiske virkninger af amlodipin og den hydroxylerede metabolit af atorvastatin DK1173172T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13066599P 1999-04-23 1999-04-23
US14530599P 1999-07-23 1999-07-23
US15112199P 1999-08-27 1999-08-27
US16659299P 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
DK1173172T3 true DK1173172T3 (da) 2006-05-15

Family

ID=27494873

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00928200T DK1173172T3 (da) 1999-04-23 2000-04-18 Synergistiske virkninger af amlodipin og den hydroxylerede metabolit af atorvastatin

Country Status (30)

Country Link
EP (1) EP1173172B1 (da)
JP (1) JP2002542289A (da)
KR (1) KR20020024581A (da)
CN (1) CN1351492A (da)
AP (1) AP2001002324A0 (da)
AT (1) ATE314846T1 (da)
AU (1) AU4647000A (da)
BG (1) BG106115A (da)
BR (1) BR0010689A (da)
CA (1) CA2370639A1 (da)
CZ (1) CZ20013793A3 (da)
DE (1) DE60025344T2 (da)
DK (1) DK1173172T3 (da)
EA (1) EA004435B1 (da)
EE (1) EE200100555A (da)
ES (1) ES2256005T3 (da)
HK (1) HK1043741A1 (da)
HU (1) HUP0201016A3 (da)
IL (1) IL146085A0 (da)
IS (1) IS6118A (da)
NO (1) NO20015128L (da)
OA (1) OA11870A (da)
PE (1) PE20010055A1 (da)
PL (1) PL351408A1 (da)
PT (1) PT1173172E (da)
SK (1) SK15382001A3 (da)
SV (1) SV2002000058A (da)
TN (1) TNSN00085A1 (da)
UY (1) UY26118A1 (da)
WO (1) WO2000064443A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030324A1 (es) * 2001-07-31 2003-04-03 Warner Lambert Co Composiciones farmaceuticas de amlodipina y atorvastatina
CN100430057C (zh) * 2005-04-08 2008-11-05 石药集团中奇制药技术（石家庄）有限公司 左旋氨氯地平和阿托伐他汀的药物组合物
KR101467110B1 (ko) * 2013-08-01 2014-11-28 한국방송공사 코로나링을 구비한 지선애자

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385929A (en) * 1994-05-04 1995-01-31 Warner-Lambert Company [(Hydroxyphenylamino) carbonyl] pyrroles
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.

Also Published As

Publication number Publication date
CZ20013793A3 (cs) 2002-05-15
TNSN00085A1 (fr) 2005-11-10
EP1173172B1 (en) 2006-01-04
BR0010689A (pt) 2002-02-19
SV2002000058A (es) 2002-02-05
EP1173172A4 (en) 2002-08-07
NO20015128L (no) 2001-12-20
PT1173172E (pt) 2006-05-31
CN1351492A (zh) 2002-05-29
NO20015128D0 (no) 2001-10-19
PL351408A1 (en) 2003-04-22
EA200101112A1 (ru) 2002-06-27
HK1043741A1 (zh) 2002-09-27
BG106115A (bg) 2002-11-29
ES2256005T3 (es) 2006-07-16
SK15382001A3 (sk) 2002-05-09
IS6118A (is) 2001-10-19
PE20010055A1 (es) 2001-01-30
JP2002542289A (ja) 2002-12-10
WO2000064443A9 (en) 2002-08-29
IL146085A0 (en) 2002-07-25
CA2370639A1 (en) 2000-11-02
EE200100555A (et) 2002-12-16
UY26118A1 (es) 2001-03-16
KR20020024581A (ko) 2002-03-30
OA11870A (en) 2006-03-27
WO2000064443A1 (en) 2000-11-02
DE60025344D1 (de) 2006-03-30
DE60025344T2 (de) 2006-09-28
EP1173172A1 (en) 2002-01-23
AU4647000A (en) 2000-11-10
EA004435B1 (ru) 2004-04-29
ATE314846T1 (de) 2006-02-15
HUP0201016A3 (en) 2003-03-28
AP2001002324A0 (en) 2001-12-31
HUP0201016A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
DK1491193T3 (da) Terapeutiske kombinationer omfattende amlodipin og atorvastatin
DK1411923T3 (da) Farmaceutisk sammensætning af amlodipin og atorvastatin
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
NO20010446D0 (no) Substituert anilidforbindelser og metoder
NO20024874L (no) Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser
IS6133A (is) Samsett salt af amlódipíni og atórvastatíni
NO20000999D0 (no) Kombinasjonsterapi omfattende amlodipin og en statinforbindelse
DK1180102T3 (da) Gensidige prodrugs af amlodipin og atorvastatin
DK1221950T3 (da) Synergitisk kombination af en NK1-receptorantagonist og en GABA-strukturanalog
AU2001283085A1 (en) Synergistic effect of amlodipine and atorvastatin
DK1173172T3 (da) Synergistiske virkninger af amlodipin og den hydroxylerede metabolit af atorvastatin
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
IT1319489B1 (it) Tavola per ponteggio e procediemnto per la sua realizzazione
ZA200108685B (en) Synergistic effects of amlodipine and atorvastatin.
FI5467U1 (fi) Amlodipiinin aspartaattijohdannainen
FR2825759B1 (fr) Meuble montable et demontable
NO20042539L (no) Amlodipin saltformer og fremgangsmåter for fremstilling derav
SI1180102T1 (en) Mutual prodrugs of amlodipine and atorvastatin
UA3449S (uk) Набір меблів
UA3448S (uk) Набір меблів
UA3447S (uk) Набір меблів